Nestlé in society Creating Shared Value and meeting our commitments 2015

Nestlé in society:
Creating Shared Value
Nutrition, health
and wellness
Rural development
Water
Environmental
sustainability
Human rights
and compliance
Our
people
Innovative therapies
We have worked to strengthen our nutrition, health and wellness strategy in recent years. Our strategy was
reinforced by the creation of new businesses, dedicated to innovative therapies to support consumers throughout
their lives: Nestlé Health Science (NHSc) and Nestlé Skin Health. Nestlé Health Science is a health science
company ‘where nutrition becomes therapy’, advancing the therapeutic role of nutrition and forging a greater,
more central and integral role for nutrition in the management of health. Nestlé Skin Health offers science-based
solutions to care for the skin, hair and nails. These new areas are built on the strength of our foods and beverages.
Nestlé Health Science (NHSc)
As part of our ambition to be a leading Nutrition, Health and
Wellness company, Nestlé offers a portfolio of nutrition
solutions, diagnostics, devices and drugs through Nestlé
Health Science that target a number of health areas, such as
inborn errors of metabolism, pediatric and acute care, obesity
care and healthy ageing, as well as gastrointestinal and brain
health. Through investing in innovation and leveraging leadingedge
science, Nestlé Health Science brings forward innovative
nutritional therapies with clinical health, economic value and
quality of life benefits.
Nestlé Health Science is a company engaged in advancing
the role of nutritional therapy to change the course of health
for consumers, patients and our partners in healthcare.
Created in 2011, NHSc is supported by the Nestlé Institute of
Health Sciences, which researches how nutrition can
empower people to improve and maintain their health, and our
R&D network, as well as through external partnerships. NHSc
is organised into three business areas:
• Consumer Care addresses specific health conditions and
includes products that people pay for themselves in a
pharmacy, retail outlet or online;
• Medical Nutrition, NHSc’s largest business, covers
products recommended by healthcare professionals and
supplies hospitals and other healthcare facilities; and
• Novel Therapeutic Nutrition works on new nutritional
therapies for specific diseases and conditions, focusing
on gastrointestinal and brain health, administered by a
health professional.
In 2015, we made progress across all three areas.
Consumer Care
We launched products in Europe and the United States. In
Europe, we launched new varieties of powder and pre-mixed
drinks to support healthy ageing, including Meritene® Mobilis, a
drink high in whey protein, leucine, calcium and vitamins,
targeting bone, muscle and joint health; Meritene® Vitachoco (a
multivitamin supplement in chocolate flavour); and Meritene®
Regenervis (a supplement of potassium and magnesium, with
antioxidant vitamins and minerals). In the United States, we
launched Boost® nutritional drinks in compact sizes, such as
Boost Calorie Smart®, a 100-calorie balanced nutritional drink,
and Boost® Compact, a complete nutritional drink. Consuming
a nutritional drink such as the new Boost® drinks can help
older adults get the nutrition they need every day.
Our support for nutritional solutions to health conditions
was reflected in our sponsorship of the inaugural Gastrodiet
conference held in Italy in November 2015, where worldleading
experts explored new scientific approaches to address
irritable bowel syndrome.
Medical Nutrition
One key area for Medical Nutrition is providing acute care with
a range of nutrition solutions for critically ill people and for
older people suffering from malnutrition or difficulty
swallowing. In 2015, we launched the Compat Ella® feeding
pump, which connects to patient data systems to ensure that
feeding rates are easily adjusted to patient needs, thereby
improving clinical outcomes and reducing care costs. We also
announced a new cooperation with GE Healthcare to develop
integrated nutritional management systems.
In the food allergy and intolerances space, another of our
key focus areas, our unrestricted grant helped experts develop
CoMiSS® (Cow’s Milk-related Symptom Score), an awareness
tool to help primary healthcare professionals assess the
likelihood of cow’s milk protein allergy, a condition estimated
to occur in 2% to 3% of infants. The tool, which has a
predictive rate of 80% and can be used by primary healthcare
professionals, can lead to earlier nutrition intervention by
several months.
We announced our investment of USD 70 million
(CHF 69.3 million) to create a Nestlé Product Technology
Centre (NPTC) in New Jersey, USA, opening in 2016. It will be
dedicated to developing innovative nutritional solutions,
focusing on applied research and product development,
sensory perception, engineering and technological expertise in
packaging.
In China, we announced the investment in a new
manufacturing facility to be built in China Medical City, Taizhou.
The new Taizhou manufacturing site will be the first FSMP
(food for special medical purpose) factory.
Nestlé in society – Creating Shared Value and meeting our commitments 2015 57